DeniseRN_TPA said:

Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

International shipping tracking for cross-border ordering orders: my experience with customs in the US when ordering from overseas:

Required FDA import alert review, delayed 10 days.

Tips: always include a copy of your prescription, declare medication properly on customs forms, keep quantities reasonable (personal use = 3 month supply max), and use a vendor who has experience shipping to your country.

lisa_labSD said:

Worth adding the genuine exception, because it is real and narrow: a change made for an identified patient where the prescriber determines it produces…

This is exactly what I could not find anywhere else. Taking it to my next appointment.

DeniseRN_TPA said:

Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. A research-chemical supplier selling lyophilised powder labelled research use only is not compounding and is not claiming to. It is a different legal universe with no pharmacy oversight, no patient relationship and no content guarantee, and conflating the two in these threads helps nobody.

Correct me if the detail matters more than I have assumed.

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.